[1] |
CAO Ailing, CAO Zhe, ZHOU Jian.
Effects of docetaxel combined with thymosin α1 on number of Treg in immune microenvironment of rats with breast cancer and its mechanism
[J]. China Oncology, 2021, 31(9): 799-806.
|
[2] |
LI Wei, ZHANG Shanling, TAO Yingjie, WANG Xudong.
Research status and progress of mechanism of T cell immune metabolism and its application combined with immune checkpoint inhibitor
[J]. China Oncology, 2021, 31(7): 640-646.
|
[3] |
CHEN Jie, WANG Yan, ZHANG Weimin, ZHAO Di, ZHANG Lingyuan, ZHAN Qimin.
Hypoxia induces expression of IL-7 in esophageal squamous cell carcinoma to promote tumor progression
[J]. China Oncology, 2021, 31(5): 361-367.
|
[4] |
YANG Bao , WANG Jing , CHEN Chao , ZHOU Jie , LI Hai .
A study on the tumorigenic effect of HIF-1α on human colorectal cancer cells in nude mice
[J]. China Oncology, 2021, 31(5): 377-382.
|
[5] |
ZHANG Jinzhong , LI Yueqi , SHI Ke , YANG Liang , GUO Dan .
Expression and clinical significance of PLK4 gene in esophageal squamous cell carcinoma and its effect on cell proliferation, invasion and migration
[J]. China Oncology, 2021, 31(12): 1185-1193.
|
[6] |
HAN Xiangchen, LI Xiaoguang, HU Xin.
Single-cell RNA sequencing and its application in breast cancer
[J]. China Oncology, 2021, 31(11): 1110-1114.
|
[7] |
FENG Bo, WANG Gaoyan, LIANG Xiaoliang, WU Zheng, GUO Yanli, SHEN Supeng, GUO Wei.
The expression level of FAM83H in esophageal squamous cell carcinoma and its effect on biological characteristics of esophageal cancer cells
[J]. China Oncology, 2020, 30(9): 674-681.
|
[8] |
YAN Fang, YING Mingzhen, CHEN Longpei, FU Qiang.
Clinical observation of albumin-bound paclitaxel plus nedaplatin as first-line treatment in advanced esophageal squamous cell carcinoma patients
[J]. China Oncology, 2020, 30(8): 632-635.
|
[9] |
WU Jingwen, YU Xuejuan, YANG Qiu’an.
Association between Onodera’s prognostic nutrition index and adverse effects of concurrent chemoradiotherapy for esophageal squamous cell carcinoma
[J]. China Oncology, 2020, 30(7): 525-530.
|
[10] |
YIN Caiqiao , FANG Chengxiang , CHEN Ting , HUANG Hui , ZHENG Yi , TAN Jiawu , ZHANG Jiqiao , ZHANG Hui .
miR-203a-3p inhibits cell proliferation and invasion of esophageal squamous cell carcinoma by targeting GATA6
[J]. China Oncology, 2020, 30(6): 441-448.
|
[11] |
JIANG Mengyi , LU Yanqiao , WANG Hongxia .
Research progress and clinical significance of breast cancer heterogeneity
[J]. China Oncology, 2020, 30(5): 394-400.
|
[12] |
CHEN Ling, ZHAN Xianbao.
Advances in immune microenvironment of peritoneal metastatic carcinomaAdvances in immune microenvironment of peritoneal metastatic carcinoma
[J]. China Oncology, 2020, 30(4): 305-309.
|
[13] |
WEN Peinan , LIN Mingshu , JIN Mian , XU Xianchou , CHEN Longyun .
Dihydromyricetin inhibits gastric cancer angiogenesis in vitro and in vivo through ERK/VEGFA/VEGFR2 signaling pathway
[J]. China Oncology, 2020, 30(2): 113-121.
|
[14] |
FAN Shouren , WU Shuhua , LI Yangyang , XU Xiaoyang , HE Shuang , WEN Feifei , LIU Liu , GUO Ningjie , JIA Zhenzhen .
The correlation between LC3 and tumor-associated macrophages in colorectal cancer and its clinical significance
[J]. China Oncology, 2020, 30(11): 849-857.
|
[15] |
FANG Yujia, ZHOU Juan, SU Chunxia.
Immune microenvironment for liver metastasis of non-small cell lung cancer and future intervention strategies
[J]. China Oncology, 2020, 30(10): 750-758.
|